Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum

被引:36
作者
Devlin, MG [1 ]
Christopoulos, A [1 ]
机构
[1] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia
关键词
cannabinoid; cross-talk; G protein; radioligand binding; serotonin;
D O I
10.1046/j.0022-3042.2002.00797.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cross-talk between cannabinoid CB, and serotonin 5-HT receptors in rat cerebellar membranes was investigated using radioligand binding. In competition against the CB, antagonist, [H-3]SR141716A, the agonist, WIN 55,212-2 yielded a biphasic isotherm. The majority of binding was to a high-affinity state that was significantly reduced by the GTP analogue, Gpp(NH)p. Interestingly, 5-HT enhanced the high-affinity binding constant of WIN 55,212-2 while attenuating the proportion of high-affinity binding. 5-HT also significantly reduced the proportion of high-affinity binding of the cannabinoid agonist, HU 210, but had no effect on the agonist, CP 55,940. The effect of 5-HT on WIN 56,212-2 binding was inhibited by the 5-HT2 receptor antagonist ritanserin as well as Gpp(NH)p, suggesting a dependence on the 5-HT2 receptor and on G protein-receptor interactions, respectively. Subsequent [H-3]WIN 55,212-2 dissociation kinetic experiments revealed that 5-HT promoted a slower-dissociating species of radiolabelled agonist-receptor complex. Our findings support a membrane-delimited cross-talk between two G protein-coupled receptors that are co-localized in certain cells of the central nervous system. Intriguingly, the cannabinoid agonist dependence of the 5-HT modulatory effect suggests that agonist-specific conformations of the CB, receptor may also be important in determining the extent of this cross-talk.
引用
收藏
页码:1095 / 1102
页数:8
相关论文
共 38 条
  • [1] A review of central 5-HT receptors and their function
    Barnes, NM
    Sharp, T
    [J]. NEUROPHARMACOLOGY, 1999, 38 (08) : 1083 - 1152
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] Control of pain initiation by endogenous cannabinoids
    Calignano, A
    La Rana, G
    Giuffrida, A
    Piomelli, D
    [J]. NATURE, 1998, 394 (6690) : 277 - 281
  • [4] Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors
    Cheer, JF
    Cadogan, AK
    Marsden, CA
    Fone, KCF
    Kendall, DA
    [J]. NEUROPHARMACOLOGY, 1999, 38 (04) : 533 - 541
  • [5] CHEN H, 1995, J PHARMACOL EXP THER, V275, P674
  • [6] Chin CN, 1998, J NEUROCHEM, V70, P366
  • [7] Qualitative and quantitative assessment of relative agonist efficacy
    Christopoulos, A
    El-Fakahany, EE
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (05) : 735 - 748
  • [8] CHRISTOPOULOS A, 2000, CURRENT PROTOCOLS PH
  • [9] SEPARATION OF CELL-TYPES FROM DEVELOPING CEREBELLUM
    COHEN, J
    BALAZS, R
    HAJOS, F
    CURRIE, DN
    DUTTON, GR
    [J]. BRAIN RESEARCH, 1978, 148 (02) : 313 - 331
  • [10] DELEAN A, 1980, J BIOL CHEM, V255, P7108